Gatter K C, Cordell J L, Turley H, Heryet A, Kieffer N, Anstee D J, Mason D Y
Nuffield Department of Pathology, John Radcliffe Hospital, Oxford, UK.
Histopathology. 1988 Sep;13(3):257-67. doi: 10.1111/j.1365-2559.1988.tb02037.x.
The production and characterization of a new monoclonal antibody, Y2/51, against platelet glycoprotein IIIa is described. A useful feature of this antibody is its ability to recognize platelets and megakaryocytes in formalin-fixed routinely processed material. It could also be used to reveal platelets both in thrombi in large vessels and in microthrombi too small to be readily apparent on conventional microscopic examination. For this purpose it was helpful to use the antibody in conjunction with a new monoclonal reagent (Ret40f) against red cell sialoglycoprotein beta which detects red cells and their precursors in routinely processed tissue. The use of these antibodies should be valuable for the detection of thrombi in a variety of situations such as renal transplant rejection, coronary artery disease and vasculitis.
本文描述了一种针对血小板糖蛋白IIIa的新型单克隆抗体Y2/51的制备及特性。该抗体的一个有用特性是它能够识别福尔马林固定的常规处理材料中的血小板和巨核细胞。它还可用于揭示大血管血栓以及常规显微镜检查中不易察觉的微小血栓中的血小板。为此,将该抗体与一种针对红细胞唾液酸糖蛋白β的新型单克隆试剂(Ret40f)联合使用很有帮助,Ret40f可在常规处理的组织中检测红细胞及其前体。在肾移植排斥、冠状动脉疾病和血管炎等多种情况下,使用这些抗体对血栓的检测应该很有价值。